Accelerating Progress and Time to Market.

The Advanced Therapies business unit of WuXi AppTec is a global Contract Development and Manufacturing Organization (CDMO) dedicated to accelerating and transforming development, manufacturing, and commercialization of cell, gene, and other advanced biopharmaceuticals.


To significantly contribute to the growth of Advanced Therapies by accelerating and transforming development and manufacturing through our enabling platforms and technologies to the benefit of patients worldwide.

Felix Hsu

Sr. VP and Global Head , WuXi Advanced Therapies

Meet Our Senior Leadership

Relive our history dating back to 1982


Commitment to Quality

WuXi Advanced Therapies provides quality and reliability in our science and services.  We are committed to maintaining the effectiveness of our quality management system, employing a continuous improvement program that ensures ongoing client satisfaction while adhering to regulatory and ISO quality management systems requirements.

WuXi AppTec is a leading global pharmaceutical and medical device open-access capability and technology platform with global operations.

Learn more about WuXi AppTec

WuXi AppTec’s Dream

“To become the most comprehensive capability and technology platform in the global pharmaceutical and healthcare industry to fulfill the dream that “every drug can be made and every disease can be treated.”

Dr. Ge Li

Chairman, WuXi AppTec Group


Philadelphia, PA HQ. Global Impact.


Square Feet of Commercial Space and Growing

View our locations


Browse our CDMO and Testing Services


Speak with our experts

Schedule a call with our technical team to find the right service.